# Donepezil

Source: https://onco.cc/drugs/da-donepezil/  
OnCo record `da-donepezil` (Treatment). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Donepezil is a tablet used for cognitive symptoms in Alzheimer’s disease. It may help some people a little. It does not slow the disease itself.

## Summary

US labeling covers mild, moderate, and severe dementia of the Alzheimer’s type. Nausea, appetite change, sleep disturbance, and slow heart rate are reasons to review the rest of the medicine list.

## Fields

- Kind: Treatment
- Status: approved
- Last checked: 2026-09-21
- Tags: dementia-atlas
- Brand: Aricept
- Modality: small molecule
- Mechanism: Cholinesterase inhibitor.
- Approvals: US 1996: Dementia of the Alzheimer’s type; EU 1997: Alzheimer’s dementia; UK 1997: Alzheimer’s dementia; JP 1999: Alzheimer’s dementia; CN 1999: Alzheimer’s dementia; AU 1998: Alzheimer’s dementia

## Sources

- FDA label index: https://www.accessdata.fda.gov/scripts/cder/daf/

## Connected records

- diagnoses: [Alzheimer’s disease](https://onco.cc/diagnoses/alzheimers-disease/)
- targets: [Acetylcholinesterase](https://onco.cc/targets/da-target-ache/)
- technologies: [Cholinesterase inhibitors](https://onco.cc/technologies/da-tech-cholinesterase-inhibitors/)

---
JSON: https://onco.cc/api/v1/entities/da-donepezil.json